265 related articles for article (PubMed ID: 10622624)
1. PCR follow-up examination after treatment of canine leishmaniosis (CaL).
Steuber S; Moritz A; Schirrmann I; Greiner M
Tokai J Exp Clin Med; 1998 Dec; 23(6):285-92. PubMed ID: 10622624
[TBL] [Abstract][Full Text] [Related]
2. Clinical follow-up examination after treatment of canine leishmaniasis.
Moritz A; Steuber S; Greiner M
Tokai J Exp Clin Med; 1998 Dec; 23(6):279-83. PubMed ID: 10622623
[TBL] [Abstract][Full Text] [Related]
3. Comparison of different tissue sampling for PCR-based diagnosis and follow-up of canine visceral leishmaniosis.
Manna L; Vitale F; Reale S; Caracappa S; Pavone LM; Morte RD; Cringoli G; Staiano N; Gravino AE
Vet Parasitol; 2004 Nov; 125(3-4):251-62. PubMed ID: 15482882
[TBL] [Abstract][Full Text] [Related]
4. Real-time PCR assay in Leishmania-infected dogs treated with meglumine antimoniate and allopurinol.
Manna L; Reale S; Vitale F; Picillo E; Pavone LM; Gravino AE
Vet J; 2008 Aug; 177(2):279-82. PubMed ID: 17553711
[TBL] [Abstract][Full Text] [Related]
5. Multicentric, controlled clinical study to evaluate effectiveness and safety of miltefosine and allopurinol for canine leishmaniosis.
Miró G; Oliva G; Cruz I; Cañavate C; Mortarino M; Vischer C; Bianciardi P
Vet Dermatol; 2009 Oct; 20(5-6):397-404. PubMed ID: 20178476
[TBL] [Abstract][Full Text] [Related]
6. Long term follow-up of dogs diagnosed with leishmaniosis (clinical stage II) and treated with meglumine antimoniate and allopurinol.
Torres M; Bardagí M; Roura X; Zanna G; Ravera I; Ferrer L
Vet J; 2011 Jun; 188(3):346-51. PubMed ID: 20594876
[TBL] [Abstract][Full Text] [Related]
7. Clinical and serological follow-up in dogs with visceral leishmaniosis treated with allopurinol and sodium stibogluconate.
Pasa S; Toz SO; Voyvoda H; Ozbel Y
Vet Parasitol; 2005 Mar; 128(3-4):243-9. PubMed ID: 15740861
[TBL] [Abstract][Full Text] [Related]
8. Long-term follow-up of dogs with leishmaniosis treated with meglumine antimoniate plus allopurinol versus miltefosine plus allopurinol.
Manna L; Corso R; Galiero G; Cerrone A; Muzj P; Gravino AE
Parasit Vectors; 2015 May; 8():289. PubMed ID: 26017164
[TBL] [Abstract][Full Text] [Related]
9. The effects of prednisone on haemostasis in leishmaniotic dogs treated with meglumine antimoniate and allopurinol.
Cortese L; Pelagalli A; Piantedosi D; Mastellone V; Di Loria A; Lombardi P; Ciaramella P; Avallone L
Vet J; 2008 Sep; 177(3):405-10. PubMed ID: 17629526
[TBL] [Abstract][Full Text] [Related]
10. Study of efficacy of miltefosine and allopurinol in dogs with leishmaniosis.
Manna L; Vitale F; Reale S; Picillo E; Neglia G; Vescio F; Gravino AE
Vet J; 2009 Dec; 182(3):441-5. PubMed ID: 18818112
[TBL] [Abstract][Full Text] [Related]
11. Characterization of circulating lymphocyte subpopulations in canine leishmaniasis throughout treatment with antimonials and allopurinol.
Miranda S; Martorell S; Costa M; Ferrer L; Ramis A
Vet Parasitol; 2007 Mar; 144(3-4):251-60. PubMed ID: 17110042
[TBL] [Abstract][Full Text] [Related]
12. Rapid clearance of circulating Leishmania kinetoplast DNA after treatment of visceral leishmaniasis.
Disch J; Oliveira MC; Orsini M; Rabello A
Acta Trop; 2004; 92(3):279-83. PubMed ID: 15533299
[TBL] [Abstract][Full Text] [Related]
13. Use of PCR-RFLP to identify Leishmania species in naturally-infected dogs.
de Andrade HM; Reis AB; dos Santos SL; Volpini AC; Marques MJ; Romanha AJ
Vet Parasitol; 2006 Sep; 140(3-4):231-8. PubMed ID: 16682124
[TBL] [Abstract][Full Text] [Related]
14. PCR identification of Leishmania in diagnosis and control of canine Leishmaniasis.
Gomes AH; Ferreira IM; Lima ML; Cunha EA; Garcia AS; Araújo MF; Pereira-Chioccola VL
Vet Parasitol; 2007 Mar; 144(3-4):234-41. PubMed ID: 17196339
[TBL] [Abstract][Full Text] [Related]
15. Allopurinol in the treatment of American cutaneous leishmaniasis.
Martinez S; Marr JJ
N Engl J Med; 1992 Mar; 326(11):741-4. PubMed ID: 1738379
[TBL] [Abstract][Full Text] [Related]
16. Short report: Contribution of quantitative real-time polymerase chain reaction to follow-up of visceral leishmaniasis patients treated with meglumine antimoniate.
Aoun K; Chouihi E; Amri F; Ben Alaya N; Raies A; Mary C; Bouratbine A
Am J Trop Med Hyg; 2009 Dec; 81(6):1004-6. PubMed ID: 19996428
[TBL] [Abstract][Full Text] [Related]
17. Periodic administration of allopurinol is not effective for the prevention of canine leishmaniosis (Leishmania infantum) in the endemic areas.
Saridomichelakis MN; Mylonakis ME; Leontides LS; Billinis C; Koutinas AF; Galatos AD; Gouletsou P; Diakou A; Kontos VI
Vet Parasitol; 2005 Jun; 130(3-4):199-205. PubMed ID: 15905034
[TBL] [Abstract][Full Text] [Related]
18. Canine leishmaniasis chemotherapy: dog's clinical condition and risk of Leishmania transmission.
João A; Pereira MA; Cortes S; Santos-Gomes GM
J Vet Med A Physiol Pathol Clin Med; 2006 Dec; 53(10):540-5. PubMed ID: 17105576
[TBL] [Abstract][Full Text] [Related]
19. Thyroid function in 36 dogs with leishmaniosis due to Leishmania infantum before and during treatment with allopurinol with or without meglumine antimonate.
Saridomichelakis MN; Xenoulis PG; Chatzis MK; Kasabalis D; Steiner JM; Suchodolski JS; Petanides T
Vet Parasitol; 2013 Oct; 197(1-2):22-8. PubMed ID: 23685064
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of renal and hepatic functions in dogs naturally infected by visceral leishmaniasis submitted to treatment with meglumine antimoniate.
Ikeda-Garcia FA; Lopes RS; Ciarlini PC; Marques FJ; Lima VM; Perri SH; Feitosa MM
Res Vet Sci; 2007 Aug; 83(1):105-8. PubMed ID: 17150234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]